| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| CMPS | $4.14 | -9.607% | 884 | 972 | $283 | $8.99 | -53.9% |
COMPASS Pathways plc
33 Broadwick Street
London W1F 0DQ
United Kingdom
We are COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression.
We want to transform the patient experience in mental health care.